Related Experiment Video
Updated: May 14, 2026
08:26
Strategy for Biobanking of Ovarian Cancer Organoids: Addressing the Interpatient Heterogeneity across Histological Subtypes and Disease Stages
Published on: February 23, 2024
[Standardizing a central nervous system tumor DNA biobank]
Diego Méndez-Rosito1, Edgar Rangel-López, María Lucinda Aguirre-Cruz
1Departamento de Neurocirugía, Instituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez, La Fama, Tlalpan, México, D.F., Mexico. diegomendezrosito@gmail.com
Cirugia Y Cirujanos
|February 5, 2013
Summary
A standardized protocol for brain tumor biopsies ensures high-quality biological material for molecular studies. This system at the National Institute of Neurology and Neurosurgery (INNN) supports future research into these leading cancers.
Area of Science:
- Neuro-oncology
- Molecular Biology
- Biobanking
Context:
- Brain tumors represent a significant global health challenge and are the primary cause of morbidity and mortality at the National Institute of Neurology and Neurosurgery (INNN).
- Effective molecular studies are crucial for advancing brain tumor research and treatment strategies.
- Establishing robust biobanking procedures is essential for collecting and preserving high-quality biological specimens.
Purpose:
- To standardize the procedures for biopsy collection, processing, and storage of biological material for molecular studies.
- To ensure the integrity and optimal quality of tissue and blood samples from brain tumor patients.
- To establish a reliable foundation for future molecular research on brain tumors at the INNN.
Summary:
- A standardized protocol was developed and implemented for the biopsy, transportation, processing, and storage of biological material from 134 brain tumor patients.
- DNA was extracted, and a comprehensive database was created, addressing technical, ethical, and legal considerations.
- Agarose gel electrophoresis confirmed the integrity of the collected biological material, with meningioma being the most common tumor type (42%).
Impact:
- The INNN biobank now possesses a standardized system for optimal quality biological material collection, processing, and storage.
- This standardized system will serve as the foundation for future molecular studies aimed at understanding brain tumor pathogenesis and developing targeted therapies.
- The initiative enhances the capacity for high-quality research, potentially leading to improved patient outcomes for brain tumor patients.
